Literature DB >> 8756925

Adrenal adenomas: relationship between histologic lipid and CT and MR findings.

M Korobkin1, T J Giordano, F J Brodeur, I R Francis, E S Siegelman, L E Quint, N R Dunnick, J P Heiken, H H Wang.   

Abstract

PURPOSE: To assess the relationship between the quantity of lipid in resected adrenal adenomas and the unenhanced computed tomographic (CT) attenuation number and the relative change in signal intensity on chemical shift magnetic resonance (MR) images.
MATERIALS AND METHODS: The percentage of lipid-rich cortical cells in histologic sections from 20 resected adrenal adenomas was assessed. The results were correlated with the corresponding unenhanced CT attenuation number or the relative change in signal intensity on chemical shift MR images, or both.
RESULTS: There was an inverse linear relationship between the percentage of lipid-rich cortical cells in the adrenal adenomas and the unenhanced CT attenuation number (R2 = .68, P = .0005). There was a similar inverse linear relationship to the relative change in MR signal intensity on chemical shift images by using both quantitative (R2 = .83, P = .004) and qualitative (R2 = .70, P = .019) assessment.
CONCLUSION: The presence and amount of histologic lipid in many adrenal adenomas accounts for their low attenuation on unenhanced CT scans and their loss in relative signal intensity on chemical shift MR images.

Entities:  

Mesh:

Year:  1996        PMID: 8756925     DOI: 10.1148/radiology.200.3.8756925

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  38 in total

Review 1.  FDG PET in the management of patients with adrenal masses and adrenocortical carcinoma.

Authors:  Désirée Deandreis; Sophie Leboulleux; Caroline Caramella; Martin Schlumberger; Eric Baudin
Journal:  Horm Cancer       Date:  2011-12       Impact factor: 3.869

2.  Cross-sectional imaging work-up of adrenal masses.

Authors:  Brinda Rao Korivi; Khaled M Elsayes
Journal:  World J Radiol       Date:  2013-03-28

3.  CT Hounsfield numbers of soft tissues on unenhanced abdominal CT scans: variability between two different manufacturers' MDCT scanners.

Authors:  Ramit Lamba; John P McGahan; Michael T Corwin; Chin-Shang Li; Tien Tran; J Anthony Seibert; John M Boone
Journal:  AJR Am J Roentgenol       Date:  2014-11       Impact factor: 3.959

Review 4.  Surgical management of adrenal metastases.

Authors:  Juan J Sancho; Frédéric Triponez; Xavier Montet; Antonio Sitges-Serra
Journal:  Langenbecks Arch Surg       Date:  2011-12-16       Impact factor: 3.445

5.  Adrenal masses falsely diagnosed as adenomas on unenhanced and delayed contrast-enhanced computed tomography: pathological correlation.

Authors:  Byung Kwan Park; Bohyun Kim; Kyungran Ko; Sun Young Jeong; Ghee Young Kwon
Journal:  Eur Radiol       Date:  2005-11-24       Impact factor: 5.315

6.  Teratoma of the adrenal gland: clinical experience and literature review.

Authors:  Cheng He; Yanli Yang; Yang Yang; Fuqin Wang; Jie Hu; Jingjing Zhang; Yu Yin; Lili Zeng; Tijiang Zhang; Heng Liu
Journal:  Gland Surg       Date:  2020-08

7.  Differentiation of adrenal adenoma and nonadenoma in unenhanced CT: new optimal threshold value and the usefulness of size criteria for differentiation.

Authors:  Sung Hee Park; Myeong-Jin Kim; Joo Hee Kim; Joon Seok Lim; Ki Whang Kim
Journal:  Korean J Radiol       Date:  2007 Jul-Aug       Impact factor: 3.500

Review 8.  The indeterminate adrenal lesion.

Authors:  Anju Sahdev; Jon Willatt; Isaac R Francis; Rodney H Reznek
Journal:  Cancer Imaging       Date:  2010-03-18       Impact factor: 3.909

Review 9.  Differential diagnosis of adrenal mass using imaging modality: special emphasis on f-18 fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography.

Authors:  Hong Je Lee; Jaetae Lee
Journal:  Endocrinol Metab (Seoul)       Date:  2014-03

Review 10.  The indeterminate adrenal mass in patients with cancer.

Authors:  A Sahdev; R H Reznek
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.